| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronavirus Infections | 6 | 2020 | 301 | 2.670 |
Why?
|
| Pneumonia, Viral | 5 | 2020 | 316 | 1.790 |
Why?
|
| Disease Models, Animal | 28 | 2019 | 2232 | 1.730 |
Why?
|
| West Nile Fever | 10 | 2008 | 21 | 1.630 |
Why?
|
| Mesocricetus | 18 | 2008 | 107 | 1.450 |
Why?
|
| Coronavirus | 2 | 2020 | 19 | 1.440 |
Why?
|
| Phlebovirus | 5 | 2008 | 5 | 1.390 |
Why?
|
| West Nile virus | 10 | 2008 | 16 | 1.370 |
Why?
|
| Adenocarcinoma | 10 | 2020 | 1169 | 1.360 |
Why?
|
| Liver | 22 | 2020 | 1230 | 1.330 |
Why?
|
| Stomach Neoplasms | 7 | 2020 | 266 | 1.100 |
Why?
|
| Biomarkers, Tumor | 11 | 2020 | 1464 | 1.080 |
Why?
|
| Lung | 9 | 2020 | 1170 | 1.080 |
Why?
|
| Immunohistochemistry | 25 | 2020 | 1753 | 1.040 |
Why?
|
| Hepatocytes | 7 | 2018 | 127 | 1.000 |
Why?
|
| Pandemics | 5 | 2020 | 740 | 0.970 |
Why?
|
| Yellow Fever | 6 | 2006 | 7 | 0.840 |
Why?
|
| Cricetinae | 25 | 2013 | 560 | 0.840 |
Why?
|
| Pancreatic Neoplasms | 4 | 2016 | 645 | 0.810 |
Why?
|
| Schistosomiasis mansoni | 1 | 2021 | 9 | 0.800 |
Why?
|
| Crohn Disease | 2 | 2021 | 730 | 0.790 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 32 | 0.770 |
Why?
|
| Intestines | 2 | 2021 | 411 | 0.750 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2020 | 5 | 0.750 |
Why?
|
| Liver Cirrhosis | 7 | 2018 | 297 | 0.710 |
Why?
|
| Pancreatitis | 5 | 2013 | 87 | 0.700 |
Why?
|
| Aged | 31 | 2021 | 18415 | 0.690 |
Why?
|
| Lung Neoplasms | 3 | 2020 | 2262 | 0.690 |
Why?
|
| Chiroptera | 1 | 2020 | 51 | 0.680 |
Why?
|
| Female | 70 | 2021 | 44532 | 0.670 |
Why?
|
| Sciuridae | 4 | 2007 | 18 | 0.660 |
Why?
|
| Liver Diseases | 2 | 2020 | 238 | 0.660 |
Why?
|
| Pneumonia | 1 | 2020 | 179 | 0.650 |
Why?
|
| Esophageal Neoplasms | 6 | 2020 | 321 | 0.630 |
Why?
|
| Betacoronavirus | 5 | 2020 | 258 | 0.630 |
Why?
|
| Neprilysin | 2 | 2012 | 42 | 0.620 |
Why?
|
| Humans | 80 | 2021 | 86643 | 0.620 |
Why?
|
| Duodenal Neoplasms | 2 | 2016 | 19 | 0.620 |
Why?
|
| Flavivirus Infections | 3 | 2013 | 5 | 0.620 |
Why?
|
| Antibodies, Viral | 12 | 2008 | 293 | 0.610 |
Why?
|
| Myocardium | 1 | 2020 | 529 | 0.600 |
Why?
|
| Monkeypox virus | 3 | 2007 | 6 | 0.600 |
Why?
|
| Hepatitis C, Chronic | 5 | 2014 | 126 | 0.590 |
Why?
|
| Amino Acid Substitution | 4 | 2008 | 339 | 0.580 |
Why?
|
| Male | 53 | 2021 | 40965 | 0.580 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 16 | 0.570 |
Why?
|
| Gastric Mucosa | 3 | 2013 | 66 | 0.550 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2014 | 108 | 0.550 |
Why?
|
| Middle Aged | 38 | 2021 | 25028 | 0.550 |
Why?
|
| Jejunal Neoplasms | 2 | 2013 | 9 | 0.540 |
Why?
|
| Aged, 80 and over | 14 | 2020 | 6509 | 0.530 |
Why?
|
| Bile Duct Neoplasms | 3 | 2012 | 79 | 0.530 |
Why?
|
| Yellow fever virus | 6 | 2005 | 7 | 0.530 |
Why?
|
| Bunyaviridae Infections | 2 | 2005 | 2 | 0.510 |
Why?
|
| Animals | 52 | 2021 | 26582 | 0.510 |
Why?
|
| Intestinal Perforation | 4 | 2007 | 34 | 0.490 |
Why?
|
| Colorectal Neoplasms | 6 | 2019 | 938 | 0.490 |
Why?
|
| Adult | 33 | 2021 | 25648 | 0.480 |
Why?
|
| Endoscopic Mucosal Resection | 3 | 2020 | 21 | 0.480 |
Why?
|
| Ileal Neoplasms | 1 | 2013 | 9 | 0.470 |
Why?
|
| Doxycycline | 1 | 2013 | 27 | 0.450 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2013 | 62 | 0.440 |
Why?
|
| Antigens, Viral | 9 | 2013 | 143 | 0.430 |
Why?
|
| Colonoscopy | 4 | 2007 | 264 | 0.430 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2012 | 12 | 0.420 |
Why?
|
| Apoptosis | 4 | 2008 | 1683 | 0.410 |
Why?
|
| Thogotovirus | 2 | 2008 | 2 | 0.400 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 241 | 0.400 |
Why?
|
| Biopsy | 7 | 2021 | 1163 | 0.400 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2008 | 46 | 0.390 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2018 | 384 | 0.390 |
Why?
|
| Flavivirus | 3 | 2013 | 6 | 0.390 |
Why?
|
| Axilla | 3 | 2019 | 99 | 0.380 |
Why?
|
| China | 3 | 2020 | 228 | 0.370 |
Why?
|
| Rift Valley Fever | 2 | 2007 | 2 | 0.370 |
Why?
|
| Liver Neoplasms | 6 | 2018 | 736 | 0.370 |
Why?
|
| Surgical Instruments | 3 | 2007 | 57 | 0.360 |
Why?
|
| Contractile Proteins | 2 | 2020 | 54 | 0.360 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2020 | 179 | 0.340 |
Why?
|
| Liver Function Tests | 6 | 2014 | 93 | 0.340 |
Why?
|
| Genome, Viral | 3 | 2007 | 74 | 0.330 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2020 | 879 | 0.330 |
Why?
|
| Viremia | 10 | 2008 | 54 | 0.330 |
Why?
|
| Granuloma | 1 | 2008 | 65 | 0.330 |
Why?
|
| Hantavirus Infections | 1 | 2008 | 2 | 0.330 |
Why?
|
| RNA, Viral | 8 | 2009 | 327 | 0.330 |
Why?
|
| Predictive Value of Tests | 6 | 2021 | 1673 | 0.320 |
Why?
|
| Rift Valley fever virus | 1 | 2007 | 1 | 0.310 |
Why?
|
| Young Adult | 7 | 2021 | 5976 | 0.310 |
Why?
|
| Gene Amplification | 3 | 2018 | 131 | 0.310 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 746 | 0.310 |
Why?
|
| Influenza A virus | 1 | 2008 | 169 | 0.300 |
Why?
|
| Virulence | 5 | 2008 | 271 | 0.300 |
Why?
|
| Chronic Disease | 5 | 2021 | 971 | 0.290 |
Why?
|
| Kidney | 5 | 2013 | 1241 | 0.290 |
Why?
|
| Intestinal Mucosa | 3 | 2006 | 797 | 0.290 |
Why?
|
| Colitis, Microscopic | 1 | 2006 | 5 | 0.290 |
Why?
|
| Aspartate Aminotransferases | 4 | 2014 | 73 | 0.280 |
Why?
|
| Antigens, CD1 | 1 | 2006 | 35 | 0.280 |
Why?
|
| Diagnosis, Differential | 4 | 2021 | 1565 | 0.280 |
Why?
|
| Colon | 6 | 2017 | 496 | 0.280 |
Why?
|
| Spleen | 10 | 2007 | 430 | 0.270 |
Why?
|
| Colonic Diseases | 1 | 2006 | 65 | 0.270 |
Why?
|
| Arenaviruses, New World | 2 | 2006 | 2 | 0.270 |
Why?
|
| Viral Nonstructural Proteins | 4 | 2009 | 37 | 0.270 |
Why?
|
| Hepacivirus | 4 | 2009 | 159 | 0.270 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2019 | 1313 | 0.270 |
Why?
|
| Lymph Nodes | 2 | 2019 | 533 | 0.260 |
Why?
|
| Mucins | 2 | 2016 | 39 | 0.260 |
Why?
|
| Influenza, Human | 1 | 2008 | 329 | 0.260 |
Why?
|
| Retrospective Studies | 9 | 2021 | 8489 | 0.260 |
Why?
|
| Phylogeny | 3 | 2007 | 1137 | 0.260 |
Why?
|
| Colonic Neoplasms | 2 | 2019 | 556 | 0.250 |
Why?
|
| Pain | 5 | 2005 | 391 | 0.250 |
Why?
|
| Lymphocytes | 1 | 2006 | 464 | 0.250 |
Why?
|
| Cytokines | 1 | 2008 | 776 | 0.240 |
Why?
|
| Bunyaviridae | 1 | 2003 | 1 | 0.240 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2020 | 930 | 0.240 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2019 | 549 | 0.230 |
Why?
|
| Barrett Esophagus | 2 | 2014 | 93 | 0.230 |
Why?
|
| Colitis | 2 | 2019 | 239 | 0.230 |
Why?
|
| Leukocyte Count | 2 | 2020 | 220 | 0.230 |
Why?
|
| Phlebotomus Fever | 1 | 2003 | 1 | 0.230 |
Why?
|
| Disease Outbreaks | 2 | 2020 | 154 | 0.230 |
Why?
|
| Thigh | 1 | 2003 | 38 | 0.230 |
Why?
|
| Abdominal Neoplasms | 1 | 2003 | 39 | 0.220 |
Why?
|
| Sarcoma, Ewing | 1 | 2003 | 42 | 0.220 |
Why?
|
| Adolescent | 7 | 2021 | 8981 | 0.220 |
Why?
|
| Viral Vaccines | 3 | 2008 | 43 | 0.220 |
Why?
|
| Esophagoscopy | 3 | 2014 | 87 | 0.220 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2011 | 70 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 2601 | 0.210 |
Why?
|
| Carcinoma, Small Cell | 1 | 2003 | 134 | 0.210 |
Why?
|
| Femur | 1 | 2003 | 116 | 0.210 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2021 | 153 | 0.210 |
Why?
|
| Hemorrhagic Fever, American | 1 | 2001 | 1 | 0.200 |
Why?
|
| Parasite Egg Count | 1 | 2021 | 6 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2014 | 199 | 0.200 |
Why?
|
| Schistosoma mansoni | 1 | 2021 | 17 | 0.200 |
Why?
|
| Viral Proteins | 1 | 2003 | 300 | 0.200 |
Why?
|
| Gastritis, Hypertrophic | 1 | 2001 | 4 | 0.200 |
Why?
|
| Rhinoscleroma | 1 | 2001 | 2 | 0.200 |
Why?
|
| Molecular Sequence Data | 4 | 2007 | 3030 | 0.200 |
Why?
|
| Gallbladder Neoplasms | 1 | 2020 | 22 | 0.190 |
Why?
|
| Lymph Node Excision | 2 | 2019 | 217 | 0.190 |
Why?
|
| Treatment Outcome | 13 | 2020 | 7993 | 0.190 |
Why?
|
| Lifting | 1 | 2020 | 12 | 0.190 |
Why?
|
| Carcinogenesis | 2 | 2019 | 195 | 0.190 |
Why?
|
| STAT6 Transcription Factor | 1 | 2020 | 28 | 0.190 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2020 | 14 | 0.190 |
Why?
|
| Hypertrophy | 1 | 2020 | 62 | 0.190 |
Why?
|
| Lymphopenia | 1 | 2020 | 28 | 0.190 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 322 | 0.190 |
Why?
|
| Patient Care Management | 1 | 2020 | 31 | 0.180 |
Why?
|
| Cytomegalovirus Infections | 1 | 2001 | 144 | 0.180 |
Why?
|
| Autopsy | 1 | 2020 | 116 | 0.180 |
Why?
|
| Respiratory System | 1 | 2020 | 116 | 0.180 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 73 | 0.180 |
Why?
|
| Sparganosis | 1 | 2019 | 1 | 0.180 |
Why?
|
| Stromal Cells | 1 | 2020 | 143 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 5 | 2018 | 853 | 0.180 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 128 | 0.180 |
Why?
|
| Rodent Diseases | 2 | 2013 | 34 | 0.170 |
Why?
|
| Organ Sparing Treatments | 1 | 2019 | 38 | 0.170 |
Why?
|
| Lymphatic System | 1 | 2019 | 53 | 0.170 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2019 | 15 | 0.170 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 136 | 0.170 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2019 | 50 | 0.170 |
Why?
|
| Fibrosis | 1 | 2020 | 203 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2019 | 381 | 0.170 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 273 | 0.170 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 107 | 0.170 |
Why?
|
| Arm | 1 | 2019 | 91 | 0.170 |
Why?
|
| Infection Control | 1 | 2020 | 115 | 0.170 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2019 | 68 | 0.170 |
Why?
|
| Chikungunya virus | 2 | 2008 | 3 | 0.170 |
Why?
|
| Alphavirus Infections | 2 | 2008 | 4 | 0.170 |
Why?
|
| Testicular Neoplasms | 1 | 2000 | 105 | 0.170 |
Why?
|
| Observer Variation | 2 | 2020 | 602 | 0.170 |
Why?
|
| Endoscopy | 3 | 2020 | 332 | 0.170 |
Why?
|
| Glucuronosyltransferase | 1 | 2020 | 184 | 0.170 |
Why?
|
| Lymphoma, T-Cell | 1 | 2019 | 48 | 0.160 |
Why?
|
| Adenoma | 2 | 2016 | 235 | 0.160 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 185 | 0.160 |
Why?
|
| Base Sequence | 4 | 2007 | 2330 | 0.160 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2018 | 23 | 0.160 |
Why?
|
| Lymphedema | 1 | 2019 | 77 | 0.160 |
Why?
|
| Endosonography | 3 | 2009 | 96 | 0.160 |
Why?
|
| Pancreas | 6 | 2006 | 239 | 0.160 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 146 | 0.160 |
Why?
|
| Radiography | 1 | 2020 | 813 | 0.160 |
Why?
|
| Anus Neoplasms | 1 | 2018 | 30 | 0.160 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2011 | 62 | 0.160 |
Why?
|
| Dissection | 1 | 2017 | 42 | 0.160 |
Why?
|
| Cetuximab | 1 | 2018 | 113 | 0.150 |
Why?
|
| Virus Replication | 3 | 2008 | 319 | 0.150 |
Why?
|
| DNA Fragmentation | 2 | 2008 | 63 | 0.150 |
Why?
|
| Breast | 1 | 2019 | 288 | 0.150 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 154 | 0.150 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 2062 | 0.150 |
Why?
|
| Colonoscopes | 2 | 2007 | 11 | 0.150 |
Why?
|
| Camptothecin | 1 | 2018 | 189 | 0.150 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2001 | 121 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 2020 | 403 | 0.150 |
Why?
|
| Urine | 2 | 2008 | 90 | 0.150 |
Why?
|
| Sex Factors | 1 | 2020 | 1054 | 0.150 |
Why?
|
| Gene Expression | 3 | 2008 | 1284 | 0.150 |
Why?
|
| Caspases | 2 | 2008 | 155 | 0.150 |
Why?
|
| Platelet Count | 2 | 2007 | 92 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1801 | 0.140 |
Why?
|
| Nociceptors | 3 | 2005 | 29 | 0.140 |
Why?
|
| CDX2 Transcription Factor | 1 | 2016 | 7 | 0.140 |
Why?
|
| Cholangiocarcinoma | 2 | 2011 | 66 | 0.140 |
Why?
|
| Mesothelioma | 1 | 2000 | 311 | 0.140 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 526 | 0.140 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 1014 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 427 | 0.140 |
Why?
|
| Vero Cells | 5 | 2008 | 100 | 0.140 |
Why?
|
| Suture Techniques | 2 | 2007 | 135 | 0.140 |
Why?
|
| Fatty Liver | 2 | 2010 | 125 | 0.140 |
Why?
|
| Inflammation | 2 | 2020 | 920 | 0.130 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 74 | 0.130 |
Why?
|
| Carcinoma | 2 | 2014 | 436 | 0.130 |
Why?
|
| Age Factors | 1 | 2020 | 1851 | 0.130 |
Why?
|
| Child, Preschool | 2 | 2020 | 3612 | 0.130 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 2903 | 0.130 |
Why?
|
| Abdominal Pain | 3 | 2013 | 137 | 0.130 |
Why?
|
| Antibody Formation | 3 | 2006 | 171 | 0.130 |
Why?
|
| Encephalitis Virus, St. Louis | 2 | 2007 | 2 | 0.130 |
Why?
|
| Feasibility Studies | 4 | 2019 | 751 | 0.130 |
Why?
|
| Narrow Band Imaging | 1 | 2014 | 6 | 0.130 |
Why?
|
| Hepatitis C | 2 | 2009 | 208 | 0.130 |
Why?
|
| Neoplasm Staging | 3 | 2020 | 1939 | 0.130 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 239 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 348 | 0.130 |
Why?
|
| Swine | 5 | 2007 | 555 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 3 | 2015 | 303 | 0.130 |
Why?
|
| Prospective Studies | 8 | 2019 | 4213 | 0.130 |
Why?
|
| Necrosis | 2 | 2013 | 204 | 0.120 |
Why?
|
| Sequence Alignment | 2 | 2007 | 351 | 0.120 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 268 | 0.120 |
Why?
|
| Child | 3 | 2020 | 6927 | 0.120 |
Why?
|
| Receptor, ErbB-2 | 1 | 2015 | 223 | 0.120 |
Why?
|
| Proteomics | 1 | 2015 | 212 | 0.120 |
Why?
|
| Smad4 Protein | 1 | 2013 | 23 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 2438 | 0.120 |
Why?
|
| Keratins | 1 | 2013 | 63 | 0.120 |
Why?
|
| Metaplasia | 1 | 2013 | 37 | 0.120 |
Why?
|
| Keratin-7 | 1 | 2013 | 10 | 0.120 |
Why?
|
| Esophageal Motility Disorders | 1 | 2013 | 12 | 0.120 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 188 | 0.120 |
Why?
|
| Panax notoginseng | 1 | 2013 | 23 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2014 | 149 | 0.120 |
Why?
|
| Tomography, Optical Coherence | 1 | 2014 | 130 | 0.120 |
Why?
|
| Hemagglutination Inhibition Tests | 3 | 2007 | 37 | 0.120 |
Why?
|
| Mucous Membrane | 1 | 2013 | 83 | 0.120 |
Why?
|
| Precision Medicine | 1 | 2017 | 395 | 0.110 |
Why?
|
| Antiviral Agents | 3 | 2007 | 510 | 0.110 |
Why?
|
| Esophagitis | 1 | 2013 | 42 | 0.110 |
Why?
|
| Constipation | 1 | 2013 | 63 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2013 | 132 | 0.110 |
Why?
|
| ras Proteins | 1 | 2013 | 128 | 0.110 |
Why?
|
| Endoscopy, Digestive System | 1 | 2013 | 65 | 0.110 |
Why?
|
| Mice | 9 | 2019 | 11352 | 0.110 |
Why?
|
| Capillaries | 1 | 2013 | 91 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 223 | 0.110 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 1991 | 0.110 |
Why?
|
| Withholding Treatment | 1 | 2013 | 112 | 0.110 |
Why?
|
| Bile Duct Diseases | 1 | 2012 | 22 | 0.110 |
Why?
|
| Genomics | 1 | 2017 | 720 | 0.100 |
Why?
|
| Viral Core Proteins | 2 | 2009 | 27 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 456 | 0.100 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 191 | 0.100 |
Why?
|
| Plant Extracts | 1 | 2013 | 244 | 0.100 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2012 | 93 | 0.100 |
Why?
|
| Bile | 1 | 2011 | 57 | 0.100 |
Why?
|
| Biopsy, Needle | 3 | 2019 | 235 | 0.100 |
Why?
|
| Ganglia, Spinal | 4 | 2005 | 72 | 0.100 |
Why?
|
| Remission Induction | 1 | 2013 | 722 | 0.100 |
Why?
|
| Viral Structural Proteins | 2 | 2008 | 19 | 0.100 |
Why?
|
| Arginase | 1 | 2010 | 16 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 645 | 0.090 |
Why?
|
| Hepatitis C Antigens | 1 | 2009 | 1 | 0.090 |
Why?
|
| Wound Healing | 3 | 2007 | 344 | 0.090 |
Why?
|
| Quantum Dots | 1 | 2009 | 19 | 0.090 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2009 | 14 | 0.090 |
Why?
|
| Genes, Viral | 2 | 2008 | 116 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 1197 | 0.090 |
Why?
|
| Serial Passage | 1 | 2008 | 3 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 2426 | 0.080 |
Why?
|
| Genes, bcl-2 | 1 | 2008 | 16 | 0.080 |
Why?
|
| Leucovorin | 2 | 2020 | 218 | 0.080 |
Why?
|
| Caspase Inhibitors | 1 | 2008 | 33 | 0.080 |
Why?
|
| Phosphatidylserines | 1 | 2008 | 20 | 0.080 |
Why?
|
| Pancreatic Ducts | 2 | 2006 | 26 | 0.080 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2008 | 47 | 0.080 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2008 | 53 | 0.080 |
Why?
|
| Pancreatitis, Chronic | 1 | 2009 | 49 | 0.080 |
Why?
|
| DNA Primers | 3 | 2005 | 543 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2008 | 122 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2011 | 1056 | 0.080 |
Why?
|
| ROC Curve | 4 | 2014 | 752 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2020 | 504 | 0.080 |
Why?
|
| Yellow Fever Vaccine | 1 | 2007 | 2 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 128 | 0.080 |
Why?
|
| Nucleoproteins | 1 | 2007 | 21 | 0.080 |
Why?
|
| Complement Fixation Tests | 1 | 2007 | 5 | 0.080 |
Why?
|
| Receptor, PAR-2 | 2 | 2004 | 3 | 0.080 |
Why?
|
| Death | 1 | 2008 | 73 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 1076 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 376 | 0.080 |
Why?
|
| Animal Diseases | 1 | 2007 | 4 | 0.080 |
Why?
|
| Antigenic Variation | 1 | 2007 | 26 | 0.080 |
Why?
|
| Italy | 1 | 2007 | 106 | 0.080 |
Why?
|
| Random Allocation | 3 | 2019 | 332 | 0.080 |
Why?
|
| Insulin, Long-Acting | 1 | 2007 | 5 | 0.080 |
Why?
|
| Encephalitis, St. Louis | 1 | 2007 | 1 | 0.080 |
Why?
|
| Encephalitis | 1 | 2007 | 104 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 322 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 266 | 0.070 |
Why?
|
| Fluorouracil | 2 | 2020 | 556 | 0.070 |
Why?
|
| Swine Diseases | 1 | 2006 | 14 | 0.070 |
Why?
|
| Mycophenolic Acid | 1 | 2007 | 87 | 0.070 |
Why?
|
| Hepatitis, Chronic | 1 | 2006 | 5 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 2705 | 0.070 |
Why?
|
| Arenaviridae Infections | 1 | 2006 | 4 | 0.070 |
Why?
|
| Antigens, CD1d | 1 | 2006 | 29 | 0.070 |
Why?
|
| Mutation | 4 | 2019 | 3968 | 0.070 |
Why?
|
| Peritonitis | 1 | 2006 | 29 | 0.070 |
Why?
|
| Peritoneum | 1 | 2006 | 57 | 0.070 |
Why?
|
| Granuloma, Pyogenic | 1 | 2006 | 5 | 0.070 |
Why?
|
| Benzamides | 1 | 2007 | 229 | 0.070 |
Why?
|
| Sigmoidoscopy | 1 | 2006 | 36 | 0.070 |
Why?
|
| Intestinal Polyps | 1 | 2006 | 26 | 0.070 |
Why?
|
| Rectal Diseases | 1 | 2006 | 24 | 0.070 |
Why?
|
| Fluorescein | 1 | 2005 | 16 | 0.070 |
Why?
|
| Caspase 7 | 1 | 2005 | 15 | 0.070 |
Why?
|
| Annexin A5 | 1 | 2005 | 20 | 0.070 |
Why?
|
| Adrenal Glands | 2 | 2007 | 76 | 0.070 |
Why?
|
| Enteritis | 1 | 2005 | 21 | 0.070 |
Why?
|
| G1 Phase | 1 | 2005 | 63 | 0.070 |
Why?
|
| Microdissection | 1 | 2005 | 18 | 0.070 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 1 | 2005 | 2 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2020 | 814 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2006 | 151 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 552 | 0.070 |
Why?
|
| Cryotherapy | 1 | 2005 | 29 | 0.070 |
Why?
|
| Clone Cells | 1 | 2005 | 213 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 1376 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2005 | 159 | 0.070 |
Why?
|
| Sodium Chloride | 1 | 2005 | 88 | 0.070 |
Why?
|
| Indoles | 1 | 2007 | 318 | 0.070 |
Why?
|
| Virus Shedding | 1 | 2005 | 26 | 0.070 |
Why?
|
| Eosinophilia | 1 | 2005 | 84 | 0.060 |
Why?
|
| Mast Cells | 1 | 2005 | 92 | 0.060 |
Why?
|
| Neurons, Afferent | 2 | 2003 | 79 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 683 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 243 | 0.060 |
Why?
|
| Esophagus | 1 | 2005 | 102 | 0.060 |
Why?
|
| Trypsin | 1 | 2004 | 95 | 0.060 |
Why?
|
| Injections | 2 | 2020 | 109 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 1204 | 0.060 |
Why?
|
| Ribavirin | 1 | 2004 | 57 | 0.060 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 248 | 0.060 |
Why?
|
| Phenotype | 2 | 2008 | 2378 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 242 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2005 | 692 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 425 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2005 | 1219 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 378 | 0.060 |
Why?
|
| Cell Line | 1 | 2008 | 2468 | 0.060 |
Why?
|
| Appendicitis | 1 | 2004 | 62 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 193 | 0.060 |
Why?
|
| Rats | 6 | 2007 | 3990 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2005 | 206 | 0.060 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2003 | 16 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2005 | 502 | 0.060 |
Why?
|
| Phyllodes Tumor | 1 | 2003 | 7 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2009 | 839 | 0.060 |
Why?
|
| Carbazoles | 1 | 2003 | 51 | 0.060 |
Why?
|
| Breast Neoplasms, Male | 1 | 2003 | 30 | 0.060 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 2003 | 34 | 0.060 |
Why?
|
| Stents | 1 | 2006 | 377 | 0.060 |
Why?
|
| Biphenyl Compounds | 1 | 2003 | 68 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2005 | 689 | 0.060 |
Why?
|
| Chicago | 2 | 2020 | 1379 | 0.060 |
Why?
|
| Cell Survival | 1 | 2005 | 969 | 0.060 |
Why?
|
| Kinetics | 1 | 2005 | 1513 | 0.060 |
Why?
|
| Catheter Ablation | 1 | 2005 | 233 | 0.060 |
Why?
|
| Cyclophosphamide | 3 | 2008 | 299 | 0.060 |
Why?
|
| Immunocompromised Host | 3 | 2008 | 140 | 0.050 |
Why?
|
| Hodgkin Disease | 1 | 2004 | 177 | 0.050 |
Why?
|
| Alanine Transaminase | 3 | 2007 | 73 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2005 | 373 | 0.050 |
Why?
|
| Encephalitis Virus, Japanese | 1 | 2002 | 6 | 0.050 |
Why?
|
| Dirofilariasis | 1 | 2002 | 2 | 0.050 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2002 | 27 | 0.050 |
Why?
|
| Actins | 1 | 2005 | 451 | 0.050 |
Why?
|
| Receptors, Thrombin | 1 | 2001 | 3 | 0.050 |
Why?
|
| Cystadenoma, Serous | 1 | 2001 | 15 | 0.050 |
Why?
|
| Cystadenoma, Papillary | 1 | 2001 | 8 | 0.050 |
Why?
|
| Heart | 1 | 2005 | 539 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 3679 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2003 | 234 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3640 | 0.050 |
Why?
|
| Hematocrit | 1 | 2001 | 68 | 0.050 |
Why?
|
| Kupffer Cells | 1 | 2001 | 13 | 0.050 |
Why?
|
| Brain | 3 | 2007 | 2216 | 0.050 |
Why?
|
| Equipment Design | 3 | 2007 | 406 | 0.050 |
Why?
|
| Klebsiella | 1 | 2001 | 6 | 0.050 |
Why?
|
| Gastroscopy | 1 | 2001 | 23 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2001 | 393 | 0.050 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2002 | 138 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 3092 | 0.050 |
Why?
|
| Physical Stimulation | 3 | 2005 | 70 | 0.050 |
Why?
|
| Biomarkers | 2 | 2006 | 1718 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2001 | 316 | 0.050 |
Why?
|
| Nasal Cavity | 1 | 2001 | 91 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 639 | 0.050 |
Why?
|
| Epididymis | 1 | 2000 | 18 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2001 | 293 | 0.050 |
Why?
|
| Models, Animal | 3 | 2007 | 263 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2000 | 129 | 0.050 |
Why?
|
| Genotype | 2 | 2020 | 1851 | 0.050 |
Why?
|
| Adenomatous Polyps | 1 | 2019 | 11 | 0.040 |
Why?
|
| International Cooperation | 1 | 2020 | 127 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2013 | 334 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 3 | 2005 | 38 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 1384 | 0.040 |
Why?
|
| Methylene Blue | 1 | 2019 | 18 | 0.040 |
Why?
|
| Interdisciplinary Communication | 1 | 2020 | 130 | 0.040 |
Why?
|
| Interleukin-16 | 1 | 2019 | 7 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 2019 | 63 | 0.040 |
Why?
|
| Indocyanine Green | 1 | 2019 | 22 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2019 | 40 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 1041 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2002 | 222 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2000 | 265 | 0.040 |
Why?
|
| Viral Envelope Proteins | 3 | 2005 | 94 | 0.040 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2019 | 51 | 0.040 |
Why?
|
| Ultrasonography, Mammary | 1 | 2019 | 82 | 0.040 |
Why?
|
| Carcinoma, Lobular | 1 | 2019 | 81 | 0.040 |
Why?
|
| Pain Measurement | 3 | 2005 | 321 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 72 | 0.040 |
Why?
|
| Risk Factors | 1 | 2008 | 5417 | 0.040 |
Why?
|
| Response Evaluation Criteria in Solid Tumors | 1 | 2018 | 56 | 0.040 |
Why?
|
| Time Factors | 4 | 2008 | 5210 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 329 | 0.040 |
Why?
|
| Organoplatinum Compounds | 1 | 2018 | 94 | 0.040 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2019 | 157 | 0.040 |
Why?
|
| Reference Values | 1 | 2019 | 674 | 0.040 |
Why?
|
| Viral Load | 2 | 2009 | 148 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2000 | 579 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 927 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2019 | 486 | 0.040 |
Why?
|
| Survival Rate | 1 | 2001 | 1863 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 1920 | 0.040 |
Why?
|
| Dogs | 2 | 2009 | 685 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 162 | 0.040 |
Why?
|
| Tissue Scaffolds | 1 | 2017 | 106 | 0.040 |
Why?
|
| Blood Cells | 2 | 2006 | 33 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 357 | 0.040 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2018 | 173 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 943 | 0.040 |
Why?
|
| Blood Chemical Analysis | 2 | 2006 | 42 | 0.040 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2016 | 15 | 0.040 |
Why?
|
| Disease Progression | 1 | 2001 | 1531 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2006 | 2207 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1805 | 0.030 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2005 | 16 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 112 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2018 | 301 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2019 | 3241 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 1204 | 0.030 |
Why?
|
| Splenectomy | 1 | 2014 | 82 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 289 | 0.030 |
Why?
|
| Amylases | 2 | 2005 | 13 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2018 | 485 | 0.030 |
Why?
|
| Substance P | 2 | 2005 | 61 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 456 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2014 | 98 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1924 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2014 | 148 | 0.030 |
Why?
|
| United States | 2 | 2020 | 6672 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2013 | 68 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2013 | 86 | 0.030 |
Why?
|
| Saponins | 1 | 2013 | 41 | 0.030 |
Why?
|
| Azoxymethane | 1 | 2013 | 82 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2005 | 1981 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 100 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2004 | 68 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 132 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2013 | 283 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1578 | 0.030 |
Why?
|
| Immunosuppressive Agents | 2 | 2008 | 977 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2013 | 196 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2011 | 84 | 0.030 |
Why?
|
| Fats | 1 | 2010 | 12 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2011 | 176 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2011 | 256 | 0.020 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2011 | 155 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2767 | 0.020 |
Why?
|
| Brazil | 1 | 2010 | 69 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2010 | 69 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 124 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2009 | 22 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 421 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 42 | 0.020 |
Why?
|
| Weaning | 1 | 2008 | 25 | 0.020 |
Why?
|
| Encephalitis Virus, Eastern Equine | 1 | 2008 | 1 | 0.020 |
Why?
|
| Sindbis Virus | 1 | 2008 | 4 | 0.020 |
Why?
|
| Vaccines, Attenuated | 1 | 2008 | 51 | 0.020 |
Why?
|
| Aedes | 1 | 2008 | 8 | 0.020 |
Why?
|
| Arthritis, Infectious | 1 | 2008 | 16 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 2360 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2008 | 270 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 865 | 0.020 |
Why?
|
| Isoindoles | 1 | 2007 | 14 | 0.020 |
Why?
|
| Kidney Cortex | 1 | 2007 | 33 | 0.020 |
Why?
|
| Carrier State | 1 | 2007 | 39 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2008 | 510 | 0.020 |
Why?
|
| Rupture | 1 | 2006 | 63 | 0.020 |
Why?
|
| Immunocompetence | 1 | 2006 | 27 | 0.020 |
Why?
|
| Partial Thromboplastin Time | 1 | 2006 | 18 | 0.020 |
Why?
|
| Lassa Fever | 1 | 2006 | 4 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 2006 | 14 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2007 | 297 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2007 | 88 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 134 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2007 | 195 | 0.020 |
Why?
|
| Point Mutation | 1 | 2007 | 246 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 190 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2006 | 91 | 0.020 |
Why?
|
| Nerve Growth Factor | 1 | 2005 | 17 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1830 | 0.020 |
Why?
|
| Video Recording | 1 | 2006 | 190 | 0.020 |
Why?
|
| Paper | 1 | 2005 | 10 | 0.020 |
Why?
|
| Culex | 1 | 2005 | 1 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 188 | 0.020 |
Why?
|
| Serum | 1 | 2005 | 25 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 916 | 0.020 |
Why?
|
| Lasers | 1 | 2005 | 106 | 0.020 |
Why?
|
| Prednisone | 1 | 2005 | 258 | 0.020 |
Why?
|
| Hindlimb | 1 | 2005 | 89 | 0.020 |
Why?
|
| TRPV Cation Channels | 1 | 2004 | 15 | 0.020 |
Why?
|
| Cadaver | 1 | 2005 | 185 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 307 | 0.020 |
Why?
|
| Receptors, Drug | 1 | 2004 | 54 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 894 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2005 | 347 | 0.020 |
Why?
|
| Diarrhea | 1 | 2005 | 182 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2005 | 265 | 0.020 |
Why?
|
| Abdomen | 1 | 2005 | 122 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2004 | 173 | 0.020 |
Why?
|
| Nausea | 1 | 2005 | 175 | 0.020 |
Why?
|
| Schools | 1 | 2004 | 71 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1458 | 0.020 |
Why?
|
| Aging | 1 | 2008 | 691 | 0.010 |
Why?
|
| Laparotomy | 1 | 2004 | 59 | 0.010 |
Why?
|
| Indole Alkaloids | 1 | 2003 | 3 | 0.010 |
Why?
|
| Vomiting | 1 | 2005 | 193 | 0.010 |
Why?
|
| Tachykinins | 1 | 2003 | 12 | 0.010 |
Why?
|
| Receptor, trkA | 1 | 2003 | 14 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 354 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 396 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2005 | 185 | 0.010 |
Why?
|
| Peroxidase | 1 | 2003 | 51 | 0.010 |
Why?
|
| Burns | 1 | 2005 | 131 | 0.010 |
Why?
|
| Pain Threshold | 1 | 2003 | 58 | 0.010 |
Why?
|
| Edema | 1 | 2003 | 71 | 0.010 |
Why?
|
| West Nile Virus Vaccines | 1 | 2002 | 1 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2005 | 352 | 0.010 |
Why?
|
| Arginine | 1 | 2003 | 136 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 107 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2003 | 143 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 2002 | 71 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2005 | 397 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 584 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 267 | 0.010 |
Why?
|
| Endocytosis | 1 | 2003 | 177 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2004 | 268 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2003 | 270 | 0.010 |
Why?
|
| Posterior Horn Cells | 1 | 2001 | 8 | 0.010 |
Why?
|
| Drug Administration Routes | 1 | 2001 | 19 | 0.010 |
Why?
|
| Capsaicin | 1 | 2001 | 44 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2003 | 249 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 2001 | 87 | 0.010 |
Why?
|
| Transgenes | 1 | 2002 | 180 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2002 | 90 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2002 | 370 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2005 | 669 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 1106 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 712 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 696 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 881 | 0.010 |
Why?
|
| Contrast Media | 1 | 2003 | 1078 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 1540 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 2818 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 1749 | 0.010 |
Why?
|